Closed-loop systems and the artificial pancreas for T1DM recommendation released in Scotland

10

Feb 2022

In January 2022, the Scottish Health Technology Group, SHTG, released a recommendation of the closed-loop systems and the artificial pancreas for type one diabetes mellitus (T1DM). A network meta-analysis and three pairwise meta-analyses found statistically significant improvements in mean percentage time in range for people with type one diabetes using a closed-loop system compared with other insulin-based therapies. The pairwise meta-analyses also reported statistically significant reductions in mean percentage time spent in hyperglycemia and hypoglycemia. High heterogeneity was present in all meta-analyses for all outcomes. The limited use of closed-loop systems in routine clinical care makes it difficult to estimate device-related adverse event rates.

The SHTG recommended that single hormone closed-loop systems should be available to people with type one diabetes (pediatric and adult) who:

  • Under their current diabetes care plan, continue to have suboptimal glycemic control, a high risk of severe hypoglycemia, or impaired awareness of hypoglycemia, or
  • Experience diabetes-related distress, measured using a validated tool, that adversely affects the quality of life or their ability to manage diabetes, and which is likely to be improved by moving to a closed-loop system.

No evidence was identified for artificial pancreas systems (multi-hormone closed-loop systems) available on the UK market.

Read more in English here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

01

Mar 2022

On February 04, 2022, NHSX announced merging with NHS Digital into the new Transformation Directorate at NHS England. NHSX's mission will remain the same - to drive the digital transformation of the NHS and social care.

Read more